Teratology · 1971 · 47 citations · 6 references
PharmacyPharmacologyToxicologyDevelopmental ToxicologyPharmaceutical ToxicologyReproductive ToxicologyPrenatal ToxicityPrenatal ToxicologyReproductive PharmacologyRodent ToxicologyDrug-induced TeratogenicityIntraperitoneal AdministrationPharmaceutical Exposure During PregnancyPharmaceutical TeratogenicityPregnancy-related ToxicityTeratogenic Effects Of DrugsTeratogenic Risk AssessmentToxoplasmosis Treatment
Abstract Pyrimethamine, a drug used in the treatment of toxoplasmosis, was much less teratogenic in golden hamsters than in Wistar rats. About 70% of rat fetuses were killed or malformed by administration of single oral doses of 5 mg to pregnant females. Less than 10% of hamster fetuses died or were malformed following single doses to the mother of 20 mg, which on a mg/kg basis was eight to nine times greater than that given to rats. In the rats repeated daily doses of 0.5 mg per female were severely teratogenic. The incidence of dead and abnormal fetuses in rats treated with 5 mg pyrimethamine was markedly reduced, from about 70 to 10%, by single intraperitoneal injections of 6 mg folinic acid; this result suggests that folinic acid might be potentially of value in lessening the teratogenic risk that may exist when pyrimethamine is employed in toxoplasmosis therapy during early pregnancy.
6
John Harrison, Emil Witschi · AIBS Bulletin · 1957 · 380 citations
J. K. Frenkel · JAMA · 1960 · 78 citations